BioCentury
ARTICLE | Clinical News

Titan preclinical data

June 10, 2002 7:00 AM UTC

In a mouse model of human head and neck squamous cell carcinoma, AD-RB94 plus cisplatin significantly reduced tumor growth without toxicity compared to a toxic dose of cisplatin alone. In addition, th...